se of Agave sisalana fibre (Sisal Fibres) Suture Material in sadyovrana (Traumatic Wounds)
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/02/062248
- Lead Sponsor
- Dr Harsha M Kencharadder
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age group between 18 to 60years.
2.Irrespective of Gender, Occupation, Place and Socio- economic status.
3.Subjects suffering with incised fresh wound measuring within 5x1x1 cm.
Exclusion Criteria
1.Infected or contaminated wounds.
2.Animal bites.
3.Wounds involving significant underlying vital structures.
4.Subjects with any bleeding disorders.
5.HIV, HBsAg, Uncontrolled type 2 DM, HTN and any other systemic disorders.
6.Burns.
7.Wounds caused by Alkalis and Poison.
8.Wounds associated with fracture.
9.Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of agave fibres as suture material in human skin in traumatic woundTimepoint: Duration of the study <br/ ><br>Incised wound will be assessed before and after the suturing on the 1st,7th and 14th day. Hence, the study duration will be 14 days. <br/ ><br>Follow up - On the completion of the treatment the subjects will be asked to visit the OPD on 28th day to rule out any complications.
- Secondary Outcome Measures
Name Time Method To give economically & human skin friendly suture material to surgical fieldTimepoint: Duration of the study -Incised wound will be assessed before & after the suturing on the 1st,7th & 14th day. Hence, the study duration will be 14 days. <br/ ><br>Follow up - On the completion of the treatment the subjects will be asked to visit the OPD on 28th day to rule out any complications.